Back to search
Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza
NCT03901001
PHASE3INTERVENTIONAL
Chinese University of Hong Kong
160 participants
Started 2023-05-08 · Completed 2025-12-31
Status: Recruiting (as of 12-23-2025)
Conditions
Influenza
Interventions
Linked Papers (from SciSciNet-V2)
Total Papers0
Background
0Result
0Derived
0Unknown
0Brief Summary
Seasonal influenza epidemics are important causes of mortality and morbidity. Cytokine dysregulation, with high levels of pro-inflammatory cytokines, occurs in patients with severe influenza A(H1N1)pdm09 virus infection, A(H5N1) infection, and A(H7N9) infection. We aim to investigate the effects of adjunctive sirolimus in adults hospitalized with influenza A or B infections involving the lower respiratory tract.
No papers linked to this trial in SciSciNet
Visit ClinicalTrials.gov for more information about this study